We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App





A Non-Invasive Skin Test Accurately Diagnoses Covid-19

By LabMedica International staff writers
Posted on 21 Jul 2022
Print article
Image: Test tube with swab for coronavirus analysis (Photo courtesy of 123rf.com)
Image: Test tube with swab for coronavirus analysis (Photo courtesy of 123rf.com)

Metabolic changes caused by Covid-19 infection can be detected in skin and saliva samples as well as in the blood, which suggest that noninvasive diagnostic tests for the disease could be available in the near future.

Investigators at the University of Surrey (United Kingdom) analyzed the correlations between serum metabolites, salivary metabolites, and skin sebum lipids in Covid-19 positive and negative individuals. In this study, 83 Covid-19 positive and negative hospitalized participants provided blood serum alongside saliva and sebum samples for analysis by liquid chromatography mass spectrometry. Participants were requested to provide all three biofluids, but due to declined consent for blood sampling, or inability to express saliva or easily provide blood, not all participants provided all three biofluids. All samples (sebum, saliva, and serum) were taken from each patient within 20 minutes of one another.

Results revealed widespread alterations to serum-sebum lipid relationships in Covid-19 positive participants versus negative controls. There was also a marked correlation between sebum lipids and the immunostimulatory hormone dehydroepiandrosterone sulfate in the Covid-19 positive group.

The biofluids were also compared in terms of their ability to differentiate COVID-19 positive participants from controls. Thus, serum performed best by multivariate analysis (sensitivity and specificity of 0.97), with the dominant changes in triglyceride and bile acid levels, in agreement with other studies identifying dyslipidemia as a hallmark of Covid-19 infection. Sebum performed well (sensitivity 0.92; specificity 0.84), with saliva performing worst (sensitivity 0.78; specificity 0.83). These findings confirmed that alterations to skin lipid profiles coincided with dyslipidaemia in serum.

Senior author Dr. Melanie Bailey, reader in analytical science the University of Surrey, said, "Covid-19 has shown us that rapid testing is vital in monitoring and identifying new illnesses. In our research, we explored the relationships between different biofluids, and what changes in one part of the human body can tell us about the overall health of a patient. Our results show that, while blood is the most accurate way of testing for this virus, skin swabs are not too far behind - in fact, the skin swab results were surprisingly accurate."

The study was published in the July 13, 2022, online edition of the journal Scientific Reports.

Related Links:
University of Surrey 

Gold Supplier
SARS-CoV-2 (ORF1a, N, RdRp) Real-Time RT-PCR Test
DiaPlexQ SARS-CoV-2 (ORF1a, N, RdRp)
New
RT-PCR Enzymes and Kits
QuantiNova Pathogen +IC Kit
New
TSI Stimulating Assay
Thyretain TSI Stimulating Reporter BioAssay
New
Automated Immunoassay Analyzer
cobas e 411

Print article
IIR Middle East

Channels

Molecular Diagnostics

view channel
Image: Metabolomic profiling reveals risk of multiple diseases all at once (Photo courtesy of BIH)

Single Blood Test Predicts Risk of Multiple Diseases Simultaneously Using AI

Prevention is better than cure. To prevent diseases from occurring in the first place, it is important to identify those individuals who are at particularly high risk as early as possible.... Read more

Technology

view channel
Image: OneDraw Blood Collection Device significantly reduces obstacles for drawing blood (Photo courtesy of Drawbridge Health)

Near Pain-Free Blood Collection Technology Enables High-Quality Testing

Blood tests help doctors diagnose diseases and conditions such as cancer, diabetes, anemia, and coronary heart disease, as well as evaluate organ functionality. They can also be used to identify disease... Read more

Industry

view channel
Image: The MC-80 digital cell morphology analyzer can screen and diagnose malignant and non-malignant blood diseases (Photo courtesy of Mindray)

Mindray Showcases Hematology Innovations at ISLH 2022

Mindray (Shenzhen, China) showcased its hematology innovations and academic achievements to medical experts from Europe and around the world at the International Symposium on Technological Innovations... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.